Elopak ASA

OSE:ELO.OL

26.75 (NOK) • At close November 17, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) NOK.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Revenue 310.24283.392292.803288.384291.923287.164283.459278.024283.392267.057272.382259.087243.354238.548236.846242.06222.793213.019209.858252.85233.048
Cost of Revenue 196.729174.821184.835178.44181.657187.216175.449174.973182.158173.912184.043169.295169.422160.682154.303154.361138.567130.882129.954164.519151.283
Gross Profit 113.511108.571107.968109.944110.26699.948108.01103.051101.23493.14588.33989.79273.93277.86682.54387.69984.22682.13779.90488.33181.765
Gross Profit Ratio 0.3660.3830.3690.3810.3780.3480.3810.3710.3570.3490.3240.3470.3040.3260.3490.3620.3780.3860.3810.3490.351
Reseach & Development Expenses 000000000000000000000
General & Administrative Expenses 000000000000000000000
Selling & Marketing Expenses 000000000000000000000
SG&A 00051.41949.854046.51747.4240000000000000
Other Expenses 87.3389.36281.38232.70982.42077.63577.5580000000000000
Operating Expenses 87.3389.36281.38283.71282.26176.50877.23677.46776.49969.52174.68673.31988.66972.10365.72472.92567.06868.7658.78465.37667.974
Operating Income 26.18119.20926.58625.81627.84622.25230.37525.49324.65816.10513.65416.473-14.7375.32516.81914.77417.15812.7921.12122.95413.79
Operating Income Ratio 0.0840.0680.0910.090.0950.0770.1070.0920.0870.060.050.064-0.0610.0220.0710.0610.0770.060.1010.0910.059
Total Other Income Expenses Net -3.7681.007-9.39-0.609-1.712-6.941-3.649-0.779-6.529-0.4243.614-3.2512.495-1.214-2.4250.982-1.443-3.964-3.481-3.7550.754
Income Before Tax 22.41320.21617.19625.20726.13415.31126.72624.71418.12915.68117.26914.556-13.8284.11114.415.75615.7158.82617.6419.19914.544
Income Before Tax Ratio 0.0720.0710.0590.0870.090.0530.0940.0890.0640.0590.0630.056-0.0570.0170.0610.0650.0710.0410.0840.0760.062
Income Tax Expense 5.12812.711.6398.5614.2941.8427.3484.3751.9474.4624.0670.9363.524.5513.5083.3494.7654.0933.7125.821-1.244
Net Income 16.9228.37215.16915.86921.50213.58619.47918.52615.4710.943.40513.874-17.348-0.4410.89212.40710.9514.73313.92813.37915.788
Net Income Ratio 0.0550.030.0520.0550.0740.0470.0690.0670.0550.0410.0130.054-0.071-0.0020.0460.0510.0490.0220.0660.0530.068
EPS 0.060.0310.0560.680.080.590.070.070.060.040.0130.052-0.064-0.0020.040.050.040.0190.060.0530.059
EPS Diluted 0.060.0310.0560.680.080.590.070.070.060.040.0130.052-0.064-0.0020.040.050.040.0190.060.0530.059
EBITDA 50.07951.48945.35847.18744.04934.3850.49745.69741.26237.535.09332.3816.48213.66531.13232.61131.07818.53835.70936.25127.169
EBITDA Ratio 0.1610.1820.1550.1640.1510.120.1780.1640.1460.140.1290.1250.0680.0570.1310.1350.1390.0870.170.1430.117